---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-22-001579"
form_type: "8-K"
ticker: "TCMD"
cik: "0001027838"
company_name: "TACTILE SYSTEMS TECHNOLOGY INC"
filed_at: "2022-02-22T23:59:59+00:00"
generated_at: "2026-06-27T05:50:29.849019+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Tactile Medical Q4 rev $61.7M (+4% YoY); net loss $7.5M; FY 2022 guidance $235-240M

## Summary
- Q4 revenue $61.7M (+4% YoY); full year 2021 revenue $208.1M (+11% YoY).
- Q4 net loss $7.5M ($0.38 loss per share) vs net income $12.1M ($0.61 EPS) in Q4 2020.
- Adjusted EBITDA Q4 $9.5M vs $10.8M prior year; full year $17.7M vs $16.0M.
- FY 2022 revenue guidance $235-240M (13-15% growth) with Omicron and staffing headwinds expected in H1.
- Qui tam lawsuit dismissed with no damages; board appointed Valerie Asbury and D. Brent Shafer in Jan 2022.

## SEC filing metadata
- accession: 0001558370-22-001579
- form_type: 8-K
- ticker: TCMD
- cik: 0001027838
- company_name: TACTILE SYSTEMS TECHNOLOGY INC
- filed_at: 2022-02-22T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1027838/000155837022001579/0001558370-22-001579-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1027838/000155837022001579/tcmd-20220222x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-22-001579
- JSON: https://secwatch.observer/filing/0001558370-22-001579.json
- Plain text: https://secwatch.observer/filing/0001558370-22-001579.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.